Despite economic disruptions and geopolitical tensions in 2022, the healthcare private equity market experienced its second strongest year on record. Although deals fell between 20% and 30% compared to 2021’s all-time high, last year was still on par with 2020 levels, reports professional information firm Wolters Kluwer.
Why such resilience? Consolidation in the healthcare industry is driving private equity momentum as firms and corporate entities continue to capitalize on investments despite a challenging financial outlook. Indeed, PWC predicts more divestitures in the sector and a track record of returns will ensure it remains a top priority for private equity firms.
With that in mind, the article covers six healthcare trends for private equity in 2023, including challenges that impact deal evaluation and due diligence. Read more.
